Position in BIIB
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$8,237,719
+$1,852,336 QoQ
Shares Held
38,127
+9.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#197
of 1,036 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. BIIB ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
97,695 | $24,811,599 | |
| 2 | ABBV |
AbbVie Inc.
|
86,259 | $21,706,214 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
179,351 | $10,334,204 | |
| 4 | LLY |
ELI LILLY & Co
|
7,425 | $8,905,768 | |
| 5 | BIIB |
Biogen Inc.
This page
|
38,127 | $8,237,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,399 | $8,009,829 | |
| 7 | MRK |
Merck & Co., Inc.
|
38,429 | $4,938,126 | |
| 8 | NVS |
Novartis AG
|
29,083 | $4,557,887 |
All Filings in BIIB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,237,719 | 38,127 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $6,385,383 | 34,830 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,725,658 | 32,534 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $4,159,395 | 29,693 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,342,075 | 26,611 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,074,521 | 22,468 | Shares | Sole | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||